Could Merck Stock Quietly Help Turn Steady Dividends Into a Millionaire Retirement?

Merck isn't exciting in the same way as GLP-1 leader Eli Lilly. But it presents an opportunity for investors who use ...

Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins

Drugmakers Novo Nordisk and Eli Lilly are battling it out in the GLP-1 weight loss market. The pill version of Novo Nordisk's ...

Fantasy Baseball: A deep dive into advanced stats for 2026 drafts

Intimidated by advanced stats in baseball? Not to worry! Corbin Young provides an outline of the key stats you need to know, and how they can help in fantasy baseball.
Canadian Mining Journal

Fuerte Announces a Positive Preliminary Economic Assessment for the Coffee Gold Project; Positioning the Company as one of Canada's Next Gold Producers

Very robust economics: After-Tax NPV (5%) of US$2.3 Billion, IRR of 47.8%, and payback achieved in 1.7 years at analyst consensus gold prices (1). After-Tax NPV (5%) of US$4.0 Billion, IRR of 69.7%, ...